Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

More documents

Recommendations

Info

262 BRITISH COLUMBIA APPENDIX 9. Healthcare Research Centres (cont’d) RESEARCH CENTRE/ URL CONTACT DESCRIPTION Down Syndrome Research Foundation (DSRF) http://www.dsrf.org/ B.C. Mental Health and Addictions Research Institute (BCMHARI) www.mhanet.ca Centre for Addictions Research of B.C. www.carbc.ca 1409 Sperling Avenue Burnaby B.C. V5B 4J8 Tel: 604-444-3773 Toll-free in Canada at 1-888-464- DSRF Fax: 604-431-9248 Contact: Naznin Virji-Babul, Director, Research naznin@dsrf.org B.C. Mental Health and Addictions Research Network PHSA Research and Networks Suite 201-601 West Broadway Vancouver B.C. V5Z 4C2 info@mhanet.ca Tel: 604.707.6390 Fax: 604.707.6399 Contact: Jane Hood Network Director Tel: 604.707.6393 University of Victoria Technology Enterprise Facility Room 273 2300 McKenzie Ave Victoria B.C. V8P 5C2 Tel: 250-472-5445 Fax: 250-472-5321 carbc@uvic.ca Contact: Timothy Stockwell, Director timstock@uvic.ca Tel: 250-472-5445 DSRF initiates and participates in research that provides insight into the unique learning style of Down’s Syndrome individuals. Data collected is analysed and pilot interventions and educational programs are developed and offered. These programs test the understanding of the brain and are evaluated to observe the impact on DSRF students. Even the slightest increase in cognitive ability, the objective that drives our work, can make a significant difference in the level of support an individual with an intellectual disability may require. DSRF specialises in imaging brain activity through magnetoencephalography (MEG). MEG records the magnetic fields in the brain using sensitive devices called SQUIDs (Superconducting Quantum Interference Devices). MEG installed at DSRF has a whole cortex capability BCMHARI aims to build capacity and promote networking among the diverse nodes in mental health research. In the addictions field, the Network is partnering with the Centre for Addictions Research of B.C. (CARBC), and will aim to further expand the partnerships and infrastructures that have been initiated across the province. BCMHARI Network has provided funding to develop four Research and Knowledge Transfer Hubs: • Alcohol and Drug Monitoring Hub: aims to describe the main patterns of alcohol and other drug use and related harms in B.C.. • Clinical Research Hub: is designed to assist researchers in the selection and employment of measures to assess cognition, substance use, and severe psychopathology. • Community Based Research Hub: aims to increase capacity for CBR in mental health and addictions by providing access to CBR-specific training, resources, and networking opportunities. • Pharmacoepidemiology Hub: is a resource for researchers interested in using B.C.’s prescription database, PharmaNet, to study patterns of utilization of pharmacological agents in the treatment of mental illness and addiction. CARB is a provincial research network involving a partnership of SFU, Thompson Rivers University, the UBC, the UNBC and UVic, and administered by UVic. Advances public policy on substance use, harm reduction, and addiction issues in B.C. through research that sheds light on their social, cultural and psychological determinants. CARB core activities include: • To build research infrastructure and capacity across B.C. for the conduct of research that will increase understanding and support more effective responses to substance use • To conduct high-quality research that increases understanding of substance use and addiction, and informs effective responses • To disseminate research findings that increase understanding of substance use and addiction in order to increase awareness of related harms and to identify effective responses • To contribute to the implementation of evidence-based policy and practice.
CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP 263 RESEARCH CENTRE/ URL CONTACT DESCRIPTION Centre for Applied Research in Mental Health & Addiction (CARMHA) http://www.carmha. ca/ SFU Faculty of Health Sciences Suite 2400, 515 W. Hastings Street Vancouver B.C. V6B 5K3 info@carmha.ca Benedikt Fischer Faculty and Interim Director Contact: Marilyn Sakiyama, Project Manager msakiyam@sfu.ca Tel: 778-782-5178 3. CANCER SPECIFIC RESEARCH INSTITUTES B.C. Cancer Research Centre www.bccrc.ca 675 West 10th Avenue Vancouver B.C. V5Z 1L3 Tel: 604-675-8000 Contact: Sue Smith, Executive Assistant to the Vice-President, Administration and Services Research Administration ssmith4@bccancer.bc.ca Tel: 604-675-8109 Fax: 604-675-8187 CARMHA mandate is to conduct research that can be applied to enhance the effectiveness, efficiency, and quality of mental health and addiction services in B.C. and beyond. CARMHA research activities often address innovative approaches to the development, implementation and dissemination and evaluation of health promotion activities, preventive strategies and treatment services, particularly those that can be applied at a system-wide, population level. CARMHA research activities are in the areas of: • Workplace Mental Health • Self-Care • System Reform • Quality, Access & Evaluation • Population Health • Primary & Collaborative Mental Health Care • Mental Health, Addictions & the Corrections System • Knowledge Translation. BCCRC performs basic, epidemiologic, and clinical research on cancer prevention, early diagnosis of cancer, the molecular and genetic characteristics of the cancer process, and basic research related to new treatments for cancer. BCCRC is the research arm of the B.C. Cancer Agency (BCCA), and is supported by the B.C. Cancer Foundation. With direct links to the cancer centres across the province, discoveries at the BCCRC are quickly translated into clinical applications. BCCRC is home to eight research departments, and BCCA Laboratory research takes place primarily in specific centres: • B.C. Cancer Agency’s Research Centre in Vancouver • Terry Fox Laboratory in Vancouver • Michael Smith Genome Sciences Centre in Vancouver • B.C. Cancer Agency’s Deeley Research Centre, Vancouver Island Centre in Victoria. BCCRC Research specialities include: • Advanced Therapeutics • Cancer Control Research • Cancer Endocrinology • Cancer Genetics and Developmental Biology • Cancer Imaging • Medical Biophysics • Molecular Oncology and Breast Cancer Program • Tumour Tissue Repository • Prostate Cancer Research Program.
Page 1:
M A G N E T I C 12 0 40 33 0 34 0 3
Page 4 and 5:
ii BRITISH COLUMBIA
Page 6 and 7:
2 BRITISH COLUMBIA EXECUTIVE SUMMAR
Page 8 and 9:
4 BRITISH COLUMBIA INTRODUCTION Wit
Page 10 and 11:
6 BRITISH COLUMBIA TABLE 1. Health
Page 12 and 13:
8 BRITISH COLUMBIA FIGURE 2. Clinic
Page 14 and 15:
10 BRITISH COLUMBIA TABLE 2. Clinic
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
22 BRITISH COLUMBIA Much clinical r
Page 28 and 29:
24 BRITISH COLUMBIA FIGURE 3. Sourc
Page 30 and 31:
26 BRITISH COLUMBIA FIGURE 7. Thera
Page 32 and 33:
28 BRITISH COLUMBIA Clinical Invest
Page 34 and 35:
30 BRITISH COLUMBIA TABLE 6. Patien
Page 36 and 37:
32 BRITISH COLUMBIA FIGURE 13. Prov
Page 38 and 39:
34 BRITISH COLUMBIA TABLE 9. Health
Page 40 and 41:
36 BRITISH COLUMBIA TABLE 10. Epide
Page 42 and 43:
38 BRITISH COLUMBIA TABLE 12. Provi
Page 44 and 45:
40 BRITISH COLUMBIA TABLE 13. Examp
Page 46 and 47:
42 BRITISH COLUMBIA TABLE 13. Examp
Page 48 and 49:
44 BRITISH COLUMBIA TABLE 14. Indep
Page 50 and 51:
46 BRITISH COLUMBIA COMPARATIVE POS
Page 52 and 53:
48 BRITISH COLUMBIA ACKNOWLEDGEMENT
Page 54 and 55:
50 BRITISH COLUMBIA APPENDIX 1-2 TA
Page 56 and 57:
52 BRITISH COLUMBIA APPENDIX 1. DES
Page 58 and 59:
54 BRITISH COLUMBIA Edward Miller C
Page 60 and 61:
56 BRITISH COLUMBIA Radiation Thera
Page 62 and 63:
58 BRITISH COLUMBIA The Unit has 15
Page 64 and 65:
60 BRITISH COLUMBIA Neonatal Resear
Page 66 and 67:
62 BRITISH COLUMBIA The B.C. Childr
Page 68 and 69:
64 BRITISH COLUMBIA The clinical tr
Page 70 and 71:
66 BRITISH COLUMBIA FRASER HEALTH A
Page 72 and 73:
68 BRITISH COLUMBIA tional therapis
Page 74 and 75:
70 BRITISH COLUMBIA PROVIDENCE HEAL
Page 76 and 77:
72 BRITISH COLUMBIA Quality control
Page 78 and 79:
74 BRITISH COLUMBIA Clinical trials
Page 80 and 81:
76 BRITISH COLUMBIA The facility ha
Page 82 and 83:
78 BRITISH COLUMBIA Staffing of the
Page 84 and 85:
80 BRITISH COLUMBIA Investigators:
Page 86 and 87:
82 BRITISH COLUMBIA Quality control
Page 88 and 89:
84 BRITISH COLUMBIA The Research Gr
Page 90 and 91:
86 BRITISH COLUMBIA Multiple Sclero
Page 92 and 93:
88 BRITISH COLUMBIA Gastroenterolog
Page 94 and 95:
90 BRITISH COLUMBIA Since the Centr
Page 96 and 97:
92 BRITISH COLUMBIA TABLE A1. Provi
Page 98 and 99:
94 BRITISH COLUMBIA FIGURE A9. Cent
Page 100 and 101:
96 BRITISH COLUMBIA The Unit suppor
Page 102 and 103:
98 BRITISH COLUMBIA TABLE A2. CFRI
Page 104 and 105:
100 BRITISH COLUMBIA Quality contro
Page 106 and 107:
102 BRITISH COLUMBIA • Knowledge
Page 108 and 109:
104 BRITISH COLUMBIA Its staffing i
Page 110 and 111:
106 BRITISH COLUMBIA APPENDIX 3. QU
Page 112 and 113:
108 BRITISH COLUMBIA APPENDIX 5. CL
Page 114 and 115:
110 BRITISH COLUMBIA APPENDIX 5. Cl
Page 116 and 117:
112 BRITISH COLUMBIA APPENDIX 6 TAB
Page 118 and 119:
114 BRITISH COLUMBIA 6.1 Clinical T
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217: 212 BRITISH COLUMBIA 6.2 Clinical T
Page 242 and 243: 238 BRITISH COLUMBIA Pediatrics INV
Page 244 and 245: 240 BRITISH COLUMBIA Pediatrics (co
Page 252 and 253: 248 BRITISH COLUMBIA APPENDICES 7-1
Page 254 and 255: 250 BRITISH COLUMBIA TABLE A3. Pati
Page 256 and 257: 252 BRITISH COLUMBIA TABLE A3. Pati
Page 258 and 259: 254 BRITISH COLUMBIA APPENDIX 8. PR
Page 260 and 261: 256 BRITISH COLUMBIA APPENDIX 8. Pr
Page 262 and 263: 258 BRITISH COLUMBIA APPENDIX 9. He
Page 288 and 289: 284 BRITISH COLUMBIA APPENDIX 10. N
Page 290 and 291: 286 BRITISH COLUMBIA Networks In Wh
Page 296 and 297: 292 BRITISH COLUMBIA APPENDIX 11. I
Page 310 and 311: 306 BRITISH COLUMBIA APPENDIX 12. P
Page 316 and 317:
312 BRITISH COLUMBIA B.C. Centre fo
Page 318 and 319:
314 BRITISH COLUMBIA University of
Page 320:
316 BRITISH COLUMBIA
show all

Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?